Cargando…

Multiple sclerosis, B cell therapy, and the COVID-19 vaccine

Detalles Bibliográficos
Autor principal:	Seachrist, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826102/ https://www.ncbi.nlm.nih.gov/pubmed/33521339 http://dx.doi.org/10.1016/j.ensci.2021.100319

Ejemplares similares

Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Multiple sclerosis patients and COVID-19
por: Mado, Hubert, et al.
Publicado: (2021)

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021)

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Piquet, Amanda L., et al.
Publicado: (2021)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021)

COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
por: Capone, Fioravante, et al.
Publicado: (2021)

The pressing questions in multiple sclerosis Care in the era of COVID-19
por: Abboud, Hesham, et al.
Publicado: (2020)

COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

Managing anxiety among multiple sclerosis patients during COVID-19 pandemic
por: Adibi, Iman, et al.
Publicado: (2021)

Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod
por: Siddiqui, Gulnaz, et al.
Publicado: (2021)

Therapeutic approaches to multiple sclerosis in Central America and the Caribbean during the COVID-19 pandemic()
por: Rivera, V.M., et al.
Publicado: (2020)

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide
por: Bollo, Luca, et al.
Publicado: (2020)

Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

Comments on “Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine” by Fujimori et al., (2021), J Neuroimmunol
por: Caravagna, Céline
Publicado: (2022)

Reorganization of multiple sclerosis health care system in Clinical Centre of Montenegro during the COVID-19 pandemic
por: Erakovic, Jevto, et al.
Publicado: (2020)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Neurofibromatosis I and multiple sclerosis
por: Bergqvist, Christina, et al.
Publicado: (2020)

Multiple sites of thrombosis without thrombocytopenia and COVID-19 vaccine: Correspondence
por: Mungunpuntipantip, Rujittika, et al.
Publicado: (2022)

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus
por: Filippi, Massimo, et al.
Publicado: (2021)

Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse
por: Möhn, Nora, et al.
Publicado: (2020)

Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis
por: Hanazono, Akira, et al.
Publicado: (2022)

Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies
por: Porwal, Mokshal H., et al.
Publicado: (2022)

Tuberous Sclerosis with Multiple Unusual Associations
por: Choudhary, Aakanksha, et al.
Publicado: (2021)

Hoarseness: could be presentation of multiple sclerosis?
por: Fatehi, Farzad
Publicado: (2009)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
por: Kogel, Ann-Kathrin, et al.
Publicado: (2021)

Coexistence of Ehlers-Danlos syndrome and multiple sclerosis
por: Kose Ozlece, Hatice, et al.
Publicado: (2015)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Hippocampal Sclerosis in a Child with Multiple Neurocysticercosis
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

The relation between genital wart and multiple sclerosis
por: Aghaei, Maryam, et al.
Publicado: (2017)

Hippocampal Sclerosis in a Child with Multiple Neurocysticercosis
por: Aulakh, Roosy
Publicado: (2017)

Unilateral Rosacea in a Patient With Multiple Sclerosis
por: Tabka, Mariem, et al.
Publicado: (2022)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ukpkh4u47paeaa33gaampfqd2